Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2008
06/26/2008CA2672893A1 Triazine derivatives and their therapeutical applications
06/26/2008CA2672811A1 4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7yl compounds for modulation of b2-adrenoreceptor activity
06/26/2008CA2672776A1 2-substituted 5-membered heterocycles as scd inhibitors
06/26/2008CA2672761A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cpti)
06/26/2008CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/25/2008EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
06/25/2008EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
06/25/2008EP1934205A1 Substituted quinolines as inhibitors of leukotriene biosynthesis
06/25/2008EP1934203A2 Alpha2c adrenoreceptor agonists
06/25/2008EP1934202A2 Nicotinic acid and picolinic acid derived near-infrared fluorophores
06/25/2008EP1934192A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors
06/25/2008EP1934191A2 Biphenyl derivatives as modulators of voltage gated ion channels
06/25/2008EP1934187A1 Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors
06/25/2008EP1934186A2 Renin inhibitors nitroderivatives
06/25/2008EP1934174A1 Azetidines as mek inhibitors for the treatment of proliferative diseases
06/25/2008EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders
06/25/2008EP1606266A4 Chemical compounds
06/25/2008EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
06/25/2008EP1458393B1 Substituted diketopiperazines as oxytocin antagonists
06/25/2008EP0986382B1 Raf kinase inhibitors
06/25/2008CN101208336A Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
06/25/2008CN101208331A Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors
06/25/2008CN101208328A Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
06/25/2008CN101208318A 1,2,4-thiadiazole compound, its use for controlling harmful organism and intermediate thereof
06/25/2008CN101208311A Pyrazine -2-carboxamide derivatives as mglur5 antagonists
06/25/2008CN101208094A Pharmacokinetically improved compounds
06/25/2008CN100396681C 2-substituted-benzothiazolyl-1,2,4-triazolinone derivative synthesis and herbicidal activity
06/25/2008CN100396680C Vla-4 inhibitors
06/25/2008CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/25/2008CN100396675C Prodrugs of proton pump inhibitors
06/25/2008CN100396672C N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
06/24/2008US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
06/24/2008US7390907 Vanilloid receptor ligands and their use in treatments
06/24/2008US7390832 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
06/24/2008US7390825 Process for the preparation of oxazolidinones and method of use thereof
06/24/2008US7390822 Delta-2 opioid receptor agonists; protecting cardiac and cerebral organs
06/24/2008US7390815 Pyrazole compounds useful as protein kinase inhibitors
06/24/2008US7390811 Respiratory syncytial virus replication inhibitors
06/24/2008US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma
06/19/2008WO2008073956A2 Cyclic sulfonamide derivatives and methods of their use
06/19/2008WO2008073461A2 Ion channel modulators
06/19/2008WO2008073459A1 Aryl sulfamide derivatives and methods of their use
06/19/2008WO2008073306A1 Organic compounds
06/19/2008WO2008072053A2 Substituted arylpyrazoles
06/19/2008WO2008071646A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008WO2008071451A1 Dihydropyridine derivatives useful as protein kinase inhibitors
06/19/2008WO2008071405A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/19/2008WO2008049123A3 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases
06/19/2008WO2008043544A8 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
06/19/2008WO2008027584A3 5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase
06/19/2008WO2006078621A9 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
06/19/2008US20080146629 Novel thiazolidin-4-one derivatives
06/19/2008US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain.
06/19/2008US20080146613 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
06/19/2008US20080146594 Thrombopoietin activity modulating compounds and methods
06/19/2008US20080146589 Chromenone derivatives
06/19/2008US20080146574 Heterocycle Substituted Carboxylic Acids
06/19/2008US20080146552 e.g. 2-(3-chloro-pyridin-2-yl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid [4-chloro-2-(2-methanesulfinyl-propylcarbamoyl)-6-methyl-phenyl]-amide; controlling insects or representatives of the order Acarina
06/19/2008US20080146550 HETEROARYLACETAMIDE INHIBITORS OF FACTOR Xa
06/19/2008US20080146539 New carboxylic acid amides, the preparation thereof and their use as medicaments
06/19/2008US20080146458 Process for the preparation of oxazolidinones and method of use thereof
06/19/2008US20080145451 Composition for relieving discomfort
06/19/2008CA2672233A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
06/19/2008CA2672167A1 Dihydropyridine derivatives as useful as protein kinase inhibitors
06/19/2008CA2671984A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008CA2671970A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/19/2008CA2671844A1 Aryl sulfamide derivatives and methods of their use
06/19/2008CA2670728A1 Pyridine derivatives used as xiap inhibitors
06/18/2008EP1932837A1 Bicyclo heterocyclic compound having antifungal action
06/18/2008EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
06/18/2008EP1931681A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands
06/18/2008EP1931657A2 Novel high affinity quinoline-based kinase ligands
06/18/2008EP1931645A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
06/18/2008EP1931632A2 Useful indole compounds
06/18/2008EP1594861B1 Triazole compounds and the therapeutic use thereof
06/18/2008EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
06/18/2008EP1283830B1 Para-amine substituted phenylamide glucokinase activators
06/18/2008CN101203509A Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
06/18/2008CN101203503A Novel thiophene derivatives
06/18/2008CN101203491A Tetrahydrocarbazole derivatives used as androgen receptor modifier
06/18/2008CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
06/17/2008US7388095 modulation of H3 Histamine receptors; e.g. 5-(4-isopropyl-morpholin-2-ylmethoxy)-1-(2,2,2-trifluoro-ethyl)-1H-indol-2-yl]-morpholin -4-yl-methanone; antagonists/inverse agonists
06/17/2008US7388021 Novel pyridyl or phenyl ureas and analogues; Purinoreceptors inhibitors; 1-(4-tert-butylphenyl)-3-(2-(3-isopropylphenoxy)pyridin-3-yl)urea; for the treatment of a thromboembolic disorders
06/17/2008US7388018 for controlling phytopathogenic harmful fungi;
06/17/2008US7388015 inhibitors of cyclin-dependent kinases (CDKs); cancer, leukemia, psoriasis
06/17/2008CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists
06/17/2008CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
06/17/2008CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
06/17/2008CA2369947C Hydroxamic acid derivative
06/12/2008WO2008070661A1 Substituted pyrimidines as adenosine receptor antagonists
06/12/2008WO2008070507A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/12/2008WO2008070447A2 Anti-viral compounds
06/12/2008WO2008069313A1 Method for producing pyrrolidine compound
06/12/2008WO2008068470A1 Antibacterial polycyclic urea compounds
06/12/2008WO2008068272A2 Antibacterial quinoline derivatives
06/12/2008WO2008068270A1 Antibacterial quinoline derivatives
06/12/2008WO2008068267A1 Antibacterial quinoline derivatives
06/12/2008WO2008067871A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
06/12/2008WO2008067644A1 Inhibitors of hiv replication
06/12/2008WO2008035305A3 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia